TWO SIGMA INVESTMENTS, LP
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1179392
NEW YORK, NY
Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,076,316
+$9,605,369 QoQ
Shares Held
2,255,820
+42.8% QoQ
Ownership
0.869%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. MRVI ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,076,316 | 2,255,820 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,470,947 | 1,579,840 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,747,576 | 845,408 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,364,351 | 1,172,248 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,211,954 | 1,332,761 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,170,180 | 1,434,471 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $596,333 | 109,419 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,271,472 | 273,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,820,072 | 254,200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,284,037 | 494,122 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $962,168 | 146,896 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,452,690 | 545,269 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,368,584 | 2,362,718 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,248,948 | 1,802,209 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,273,042 | 1,556,467 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,742,645 | 538,294 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,678,747 | 622,272 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,323,123 | 632,921 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,048,272 | 406,880 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,458,068 | 29,708 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $18,322,641 | 439,076 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,919,421 | 222,206 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,083,953 | 288,198 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||